Please provide your email address to receive an email when new articles are posted on . I believe intravitreal injections are best performed in the office for many reasons. First of all, it is safe.
Please provide your email address to receive an email when new articles are posted on . An expert panel that was convened to update guidelines for giving intravitreal injections makes clear that ...
This study reviewed 15,895 intravitreal injections (9453 ranibizumab, 5386 bevacizumab, 935 triamcinolone, and 121 pegaptanib) that were performed for various indications over a 5-year period. Of the ...
Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...
LONG BEACH, Calif. -- Prefilled syringes to treat macular degeneration caused larger and more frequent spikes in intraocular pressure (IOP) as compared with medication drawn from vials, a study of ...
A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...
Repeated intravitreal injections of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin) may increase the risk of uncontrolled glaucoma, according to a Canadian study in JAMA ...
We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results